دورية أكاديمية
Long-term outcomes of coronary artery bypass graft surgery in patients with widespread atherosclerotic lesions of the coronary and peripheral vascular basins (based on the REGATA long-term antithrombotic therapy registry)
| العنوان: | Long-term outcomes of coronary artery bypass graft surgery in patients with widespread atherosclerotic lesions of the coronary and peripheral vascular basins (based on the REGATA long-term antithrombotic therapy registry) |
|---|---|
| المؤلفون: | E. N. Krivosheeva, A. L. Komarov, D. M. Galyautdinov, E. E. Vlasova, R. S. Akchurin, E. P. Panchenko |
| المصدر: | Атеротромбоз, Vol 11, Iss 2, Pp 30-43 (2022) |
| بيانات النشر: | «REMEDIUM GROUP» Ltd., 2022. |
| سنة النشر: | 2022 |
| المجموعة: | LCC:Internal medicine |
| مصطلحات موضوعية: | мультифокальный атеросклероз, антитромботическая терапия, ривароксабан, риск тромботических осложнений, многососудистая ибс, коронарное шунтирование, эндартерэктомия, Internal medicine, RC31-1245 |
| الوصف: | Introduction. Multifocal atherosclerosis (MFA) in patients with CHD is a key risk factor for thrombotic complications (TC). There are little data on the long-term prognosis in patients with multivessel CHD combined with carotid artery lesions.Objective. To assess prognostic negative outcomes (thrombosis and bleeding) in patients with CHD and MFA undergoing revascularization procedures – coronary artery bypass graft surgery and, in case of high risk of ischemic stroke, carotid endarterectomy.Materials and methods. A total of 189 patients with stable multivessel coronary artery disease who successfully underwent coronary bypass graft surgery and had concomitant atherosclerosis of the carotid arteries ≥50% were included in the study. The exclusion criterion was chronic use of oral anticoagulants. The choice of antithrombotic therapy after the surgical intervention was determined by the attending physicians. The efficacy endpoint was defined as the sum of TC including cardiovascular death, acute coronary syndrome, ischemic stroke, acute lower limb ischemia, and the need for emergency revascularization of the carotid or coronary basins. BARC bleeding types 2-5 were considered as a safety endpoint.Results. The median follow-up period was 37 months. [MR 25.0; 45.0]. The cumulative incidence of TC was 11.1%, BARC 2-5 bleeding was 4.8%. One or two antiplatelet agents were prescribed at discharge in 87.3% of cases, and in 12.7% – a combination of acetylsalicylic acid (ASA) and oral anticoagulant (OAC) for up to 6 months. The incidence of thrombotic complications was not significantly different in the mono- or dual antiplatelet therapy groups. The combination therapy group (OAC + ASA) was characterized by the highest number of comorbidities. When analyzing the TC for the first 6 months. (before anticoagulant withdrawal) there was no significant difference between the groups of antiplatelet therapy and the combination of ASA and OAC (Log-Rank, p = 0.4669). The proportion of patients who survived the entire follow-up period without developing TC was significantly higher in the group compared to the initial combination therapy group: 0.83 versus 0.50 (Log-Rank, p = 0.0101).Conclusion. Despite complete revascularization, the incidence of TC during the two years of follow-up was high. In the combination therapy group, anticoagulant withdrawal led to an increased incidence of TC. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | Russian |
| تدمد: | 2307-1109 2658-5952 |
| Relation: | https://www.aterotromboz.ru/jour/article/view/254; https://doaj.org/toc/2307-1109; https://doaj.org/toc/2658-5952 |
| DOI: | 10.21518/2307-1109-2021-11-2-30-43 |
| URL الوصول: | https://doaj.org/article/ff790b7b2d4e4407af1a011c7f543fbb |
| رقم الأكسشن: | edsdoj.ff790b7b2d4e4407af1a011c7f543fbb |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 23071109 26585952 |
|---|---|
| DOI: | 10.21518/2307-1109-2021-11-2-30-43 |